Credit Suisse’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$23K Buy
2019
Q3
Sell
2019
Q2
$72K Sell
2019
Q1
$1.03M Buy
2016
Q3
Sell
2016
Q2
$89K Sell
2016
Q1
$88K Sell
2015
Q4
$103K Buy
2015
Q3
$141K Sell
2015
Q2
$234K Buy
2015
Q1
$226K Sell
2014
Q4
$316K Buy
2014
Q3
$368K Buy
2014
Q2
$636K Sell
2014
Q1
$989K Buy
2013
Q4
$104K Buy